Traitements4programmes
Essais1liés
Publications8liées
SourceDBlocale

Traitements

4
MoléculeIndication / populationPhaseObjectifPaysRésultat
CBPPatients with uncontrolled or newly diagnosed hypertension will be randomized to have hypertension management decisions made on the basis of the unattended automated blood pressure (uAOBP) , home BP, and central BP monitoring. This study evaluates the optimal guiding strategy for hypertension will help define which BP monitoring is the most effective strategy to guide the clinical management of hypertension. Hypertension NA À vérifier Taiwan À vérifier
Home BPPatients with uncontrolled or newly diagnosed hypertension will be randomized to have hypertension management decisions made on the basis of the unattended automated blood pressure (uAOBP) , home BP, and central BP monitoring. This study evaluates the optimal guiding strategy for hypertension will help define which BP monitoring is the most effective strategy to guide the clinical management of hypertension. Hypertension NA À vérifier Taiwan À vérifier
uAOBPPatients with uncontrolled or newly diagnosed hypertension will be randomized to have hypertension management decisions made on the basis of the unattended automated blood pressure (uAOBP) , home BP, and central BP monitoring. This study evaluates the optimal guiding strategy for hypertension will help define which BP monitoring is the most effective strategy to guide the clinical management of hypertension. Hypertension NA À vérifier Taiwan À vérifier
uAOBPPatients with uncontrolled or newly diagnosed hypertension will be randomized to have hypertension management decisions made on the basis of the unattended automated blood pressure (uAOBP) , home BP, and central BP monitoring. This study evaluates the optimal guiding strategy for hypertension will help define which BP monitoring is the most effective strategy to guide the clinical management of hypertension. Hypertension NA À vérifier Taiwan À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
uAOBP Hypertension NA NCT03578848 GYMNs — Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies UNKNOWN

Publications

8
MoléculeIndication / populationTitreJournalDate
CBP Targeted discovery of anti-skin aging peptides from Camelus bactrianus placenta: Multi-activity screening, network pharmacology, and in vitro validation focusing on MMP-1 inhibition. Journal of ethnopharmacology
CBP Bu-Sui-Dan promotes angiogenesis to mitigate age-related osteoporosis via the ZEB1/Notch1 axis. Journal of ethnopharmacology
CBP Unlocking raw-corncob consolidated bioprocessing for malic acid production by DyP-enabled lignin deconstruction in . Synthetic and systems biotechnology
Home BP Association between orthostatic blood pressure change and masked and white coat hypertension: the Nagahama study. Journal of hypertension
Home BP Measurement of blood pressure in European Society of Hypertension Excellence Centres: a survey by the Young Investigators Group of the European Society of Hypertension. Blood pressure
Home BP Reassessing blood pressure control: the role of long-term blood pressure variability and time in target range. Blood pressure
uAOBP Association of Anxiety with Discrepancies Between Unattended and Attended Office Blood Pressure Measurement. American journal of hypertension
uAOBP Comparison of unattended, attended and routine clinic systolic blood pressure measurements and determinants of blood pressure difference between attended and unattended BP. Journal of human hypertension